Early-Morning vs Spot Posterior Oropharyngeal Saliva for Diagnosis of SARS-CoV-2 Infection: Implication of Timing of Specimen Collection for Community-Wide Screening.
SARS-CoV-2
coronavirus
diagnosis
saliva
screening
Journal
Open forum infectious diseases
ISSN: 2328-8957
Titre abrégé: Open Forum Infect Dis
Pays: United States
ID NLM: 101637045
Informations de publication
Date de publication:
Jun 2020
Jun 2020
Historique:
received:
18
05
2020
accepted:
29
05
2020
entrez:
25
6
2020
pubmed:
25
6
2020
medline:
25
6
2020
Statut:
epublish
Résumé
Posterior oropharyngeal saliva is increasingly recognized as a valid respiratory specimen for SARS-CoV-2 diagnosis. It is easy to collect and suitable for community-wide screening. The optimal timing of collection is currently unknown, and we speculate that an early-morning specimen before oral hygiene and breakfast would increase the diagnostic yield. Posterior oropharyngeal saliva was collected at 5 different time points within the same day from 18 patients with previously confirmed SARS-CoV-2 infection by molecular testing. Cycle threshold (Ct) values were compared. There was an overall trend of lower Ct values from specimens collected in the early morning, with a gradual decrease of viral load towards nighttime, but reaching statistical significance only when compared with the specimens collected at bedtime. Eight out of 13 subjects had a higher viral load in the early morning than the rest of the 4 time points (before lunch, before teatime at 3 pm, before dinner, before bedtime). The result suggests a diurnal variation of viral shedding from the upper respiratory tract with a trend showing higher viral load in the early morning. For community screening purposes, posterior oropharyngeal saliva could be taken throughout the day, but preferably in the early morning to maximize the yield.
Sections du résumé
BACKGROUND
BACKGROUND
Posterior oropharyngeal saliva is increasingly recognized as a valid respiratory specimen for SARS-CoV-2 diagnosis. It is easy to collect and suitable for community-wide screening. The optimal timing of collection is currently unknown, and we speculate that an early-morning specimen before oral hygiene and breakfast would increase the diagnostic yield.
METHODS
METHODS
Posterior oropharyngeal saliva was collected at 5 different time points within the same day from 18 patients with previously confirmed SARS-CoV-2 infection by molecular testing. Cycle threshold (Ct) values were compared.
RESULTS
RESULTS
There was an overall trend of lower Ct values from specimens collected in the early morning, with a gradual decrease of viral load towards nighttime, but reaching statistical significance only when compared with the specimens collected at bedtime. Eight out of 13 subjects had a higher viral load in the early morning than the rest of the 4 time points (before lunch, before teatime at 3 pm, before dinner, before bedtime).
CONCLUSIONS
CONCLUSIONS
The result suggests a diurnal variation of viral shedding from the upper respiratory tract with a trend showing higher viral load in the early morning. For community screening purposes, posterior oropharyngeal saliva could be taken throughout the day, but preferably in the early morning to maximize the yield.
Identifiants
pubmed: 32577428
doi: 10.1093/ofid/ofaa210
pii: ofaa210
pmc: PMC7299521
doi:
Types de publication
Journal Article
Langues
eng
Pagination
ofaa210Informations de copyright
© The Author(s) 2020. Published by Oxford University Press on behalf of Infectious Diseases Society of America.
Références
N Engl J Med. 2020 Apr 30;382(18):1708-1720
pubmed: 32109013
Clin Infect Dis. 2020 Apr 09;:
pubmed: 32270184
J Dent Res. 2020 Apr 9;:22034520918518
pubmed: 32271653
Clin Infect Dis. 2020 Feb 12;:
pubmed: 32047895
J Pathol. 2004 Jun;203(2):631-7
pubmed: 15141377
Clin Infect Dis. 2020 Mar 26;:
pubmed: 32215622
Int J Oral Sci. 2020 Apr 17;12(1):11
pubmed: 32300101
J Infect. 2020 Jul;81(1):e45-e50
pubmed: 32298676
BMC Med. 2017 Oct 27;15(1):192
pubmed: 29073910
Lancet Infect Dis. 2020 May;20(5):565-574
pubmed: 32213337
Int J Oral Sci. 2020 Feb 24;12(1):8
pubmed: 32094336
Lancet. 2020 Feb 15;395(10223):514-523
pubmed: 31986261
Clin Infect Dis. 2020 Apr 22;:
pubmed: 32318718
Infect Control Hosp Epidemiol. 2020 May;41(5):493-498
pubmed: 32131908
Emerg Microbes Infect. 2020 Dec;9(1):221-236
pubmed: 31987001
Clin Transl Allergy. 2013 Mar 28;3(1):8
pubmed: 23537329
World Allergy Organ J. 2008 May;1(5):74-8
pubmed: 23282322
Clin Microbiol Rev. 2007 Oct;20(4):660-94
pubmed: 17934078
Clin Microbiol Infect. 2019 Mar;25(3):372-378
pubmed: 29906597
J Gen Virol. 2006 Jun;87(Pt 6):1691-5
pubmed: 16690935
Lancet. 2003 May 24;361(9371):1767-72
pubmed: 12781535
BMJ. 2020 Apr 2;369:m1375
pubmed: 32241884
Emerg Microbes Infect. 2017 Jun 7;6(6):e49
pubmed: 28588283
J Infect. 2020 Jun;80(6):e41-e42
pubmed: 32283150
J Virol. 2011 Apr;85(8):4025-30
pubmed: 21289121
J Med Virol. 2020 Apr 15;:
pubmed: 32293716
Oral Dis. 2020 Apr 20;:
pubmed: 32311181
Lancet Glob Health. 2017 Aug;5(8):e760-e771
pubmed: 28625793
Nat Med. 2020 May;26(5):681-687
pubmed: 32327758
J Clin Microbiol. 2020 Apr 21;:
pubmed: 32317257
Cell. 2020 May 14;181(4):894-904.e9
pubmed: 32275855
J Hosp Infect. 2020 Mar;104(3):254-255
pubmed: 31962139
Euro Surveill. 2020 Mar;25(10):
pubmed: 32183930